ISRCTN96896687进行中（未招募）1 期
Intravitreal panitumumab for prevention of myopic axial elongation in highly myopic adult eyes with myopic macular degeneration
fa Eye Research Institute0 个研究点目标入组 20 人开始时间: 2023年3月3日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged <50 years old
- •2. Axial length >26.0 mm
- •3. Myopic macular degeneration of stage 4 (foveal patchy atrophy)
- •4. Best corrected visual acuity >1.0 logMAR (logarithm of the minimal angle of resolution) (20/200 Snellen equivalent)
排除标准
- •Not meeting the inclusion criteria
研究者
相似试验
招募中
1 期
Intravitreal Panitumumab for Prevention of Myopic Axial Elongation in Highly Myopic Adult Eyes with Myopic Macular DegeneratioMyopic ophthalmopathyDRKS00027302fa Eye Research Institute40
进行中（未招募）
2 期
sing panitumumab with ranibizumab injected into the eye to treat exudative age-related macular degeneratioExudative age-related macular degenerationEye DiseasesISRCTN85022211fa Eye Research Institute200
尚未招募
3 期
To investigate the role of Intravitreal Aflibercept (Eylea) in the treatment of patients whose wet Age related Macular degeneration is not adequately controlled with conventional anti VEGF (intravitreal Avastin or Lucentis) treatment.ACTRN12613001020774Greenlane Clinical Centre Auckland District Health Board50
招募中
1 期
eovascular glaucoma prevention by intravitreal injections of anti-VEGF in patients treated by protontherapy in case of large choroidal melanomaEUCTR2016-003329-40-FRCHU de Nice56
进行中（未招募）
1 期
Preoperative intravitreal ranibizumab for persistent diabetic vitreous haemorrhage: A randomized, double-masked, controlled study - Vitreous Haemorrhage StudyEUCTR2009-015559-25-GBKing's College Hospital NHS Foundation Trust24